By Josh White
Date: Thursday 31 Aug 2023
(Sharecast News) - Biopharmaceutical developer Ovoca Bio's shares were plummeting on Thursday, after it released a summary of the top-line results from its phase two dose-ranging study evaluating Orenetide.
By Josh White
Date: Wednesday 08 Mar 2023
(Sharecast News) - Biopharmaceutical company Ovoca Bio announced on Wednesday that it will be disposing of certain Russian assets to the private Russian company Desirix.
By Josh White
Date: Friday 29 Jul 2022
(Sharecast News) - Women's health-focussed biopharmaceutical company Ovoca Bio announced the successful completion of participant enrollment in a phase 2 dose-ranging study assessing 'orenetide' on Friday.
Currency | UK Pounds |
Share Price | 0.83p |
Change Today | 0.075p |
% Change | 10.00 % |
52 Week High | 14.00 |
52 Week Low | 0.55 |
Volume | 142,115 |
Shares Issued | 88.46m |
Market Cap | £0.73m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
13:45 | 25,122 @ 0.75p |
11:35 | 164 @ 0.76p |
11:34 | 1,100 @ 0.75p |
11:34 | 100,000 @ 0.78p |
11:01 | 15,000 @ 0.79p |
CEO | Kirill Andreyevich Golovanov |
You are here: research